SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ZIL'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XJ7_D_ADND303_1 (5'/3'-NUCLEOTIDASESURE) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1 (Mycobacteriumtuberculosis) | 5 / 10 | LEU H 103LEU H 32GLY H 100SER H 98ALA H 76 | NoneNoneNoneZIL H 301 ( 2.9A)None | 1.12A | 4xj7C-4u0gH:undetectable4xj7D-4u0gH:undetectable | 4xj7C-4u0gH:24.074xj7D-4u0gH:24.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_O_BEZO801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 5 / 6 | PHE A 83SER A 110HIS A 135PRO A 137MET A 164 | ZIL A 301 (-4.5A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 (-3.8A)ZIL A 301 ( 2.9A) | 0.49A | 5dzka-4u0gA:27.35dzko-4u0gA:undetectable | 5dzka-4u0gA:100.005dzko-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_P_BEZP801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 4 / 5 | SER A 110ALA A 111HIS A 135MET A 164 | ZIL A 301 ( 4.0A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 ( 2.9A) | 0.41A | 5dzkb-4u0gA:27.75dzkp-4u0gA:undetectable | 5dzkb-4u0gA:100.005dzkp-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_P_BEZP801_1 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 5 / 6 | PHE A 83SER A 110ALA A 111HIS A 135MET A 164 | ZIL A 301 (-4.5A)ZIL A 301 ( 4.0A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 ( 2.9A) | 0.49A | 5dzkB-4u0gA:27.75dzkP-4u0gA:undetectable | 5dzkB-4u0gA:100.005dzkP-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_Q_BEZQ801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 4 / 5 | SER A 110ALA A 111HIS A 135MET A 164 | ZIL A 301 ( 4.0A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 ( 2.9A) | 0.42A | 5dzkc-4u0gA:27.35dzkq-4u0gA:undetectable | 5dzkc-4u0gA:100.005dzkq-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_R_BEZR801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 6 / 7 | PHE A 83SER A 110ALA A 111HIS A 135PRO A 137MET A 164 | ZIL A 301 (-4.5A)ZIL A 301 ( 4.0A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 (-3.8A)ZIL A 301 ( 2.9A) | 0.47A | 5dzkD-4u0gA:27.45dzkR-4u0gA:undetectable | 5dzkD-4u0gA:100.005dzkR-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_R_BEZR801_1 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 6 / 8 | PHE A 83SER A 110ALA A 111HIS A 135PRO A 137MET A 164 | ZIL A 301 (-4.5A)ZIL A 301 ( 4.0A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 (-3.8A)ZIL A 301 ( 2.9A) | 0.47A | 5dzkd-4u0gA:27.45dzkr-4u0gA:undetectable | 5dzkd-4u0gA:100.005dzkr-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_S_BEZS801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 4 / 6 | PHE A 83SER A 110HIS A 135MET A 164 | ZIL A 301 (-4.5A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 ( 2.9A) | 0.50A | 5dzke-4u0gA:27.65dzks-4u0gA:undetectable | 5dzke-4u0gA:100.005dzks-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_T_BEZT801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 4 / 5 | SER A 110ALA A 111HIS A 135MET A 164 | ZIL A 301 ( 4.0A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 ( 2.9A) | 0.42A | 5dzkf-4u0gA:27.45dzkt-4u0gA:undetectable | 5dzkf-4u0gA:100.005dzkt-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_T_BEZT801_1 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 6 / 8 | PHE A 83SER A 110ALA A 111HIS A 135PRO A 137MET A 164 | ZIL A 301 (-4.5A)ZIL A 301 ( 4.0A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 (-3.8A)ZIL A 301 ( 2.9A) | 0.46A | 5dzkF-4u0gA:27.45dzkT-4u0gA:undetectable | 5dzkF-4u0gA:100.005dzkT-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_U_BEZU801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 5 / 6 | PHE A 83SER A 110ALA A 111HIS A 135MET A 164 | ZIL A 301 (-4.5A)ZIL A 301 ( 4.0A)ZIL A 301 ( 4.0A)ZIL A 301 (-3.7A)ZIL A 301 ( 2.9A) | 0.49A | 5dzkg-4u0gA:27.45dzku-4u0gA:undetectable | 5dzkg-4u0gA:100.005dzku-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_W_BEZW801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1 (Mycobacteriumtuberculosis;Mycobacteriumtuberculosis) | 4 / 5 | PHE A 147ILE H 71GLY H 127ILE H 146 | ZIL H 301 ( 4.8A)ZIL H 301 (-3.6A)ZIL H 301 ( 3.5A)ZIL H 301 ( 3.3A) | 0.38A | 5dzkB-4u0gA:27.75dzkI-4u0gA:31.45dzkW-4u0gA:undetectable | 5dzkB-4u0gA:100.005dzkI-4u0gA:41.585dzkW-4u0gA:1.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DZK_Y_BEZY801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1 (Mycobacteriumtuberculosis;Mycobacteriumtuberculosis) | 4 / 5 | PHE A 147ILE H 71GLY H 127ILE H 146 | ZIL H 301 ( 4.8A)ZIL H 301 (-3.6A)ZIL H 301 ( 3.5A)ZIL H 301 ( 3.3A) | 0.35A | 5dzkd-4u0gA:27.45dzkk-4u0gA:31.45dzky-4u0gA:undetectable | 5dzkd-4u0gA:100.005dzkk-4u0gA:41.585dzky-4u0gA:1.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M5K_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 4 / 4 | GLN A 136THR A 183THR A 167LEU A 86 | NoneNoneNoneZIL A 301 ( 4.3A) | 1.49A | 5m5kA-4u0gA:undetectable | 5m5kA-4u0gA:18.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M5K_C_ADNC502_2 (ADENOSYLHOMOCYSTEINASE) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 4 / 4 | GLN A 136THR A 183THR A 167LEU A 86 | NoneNoneNoneZIL A 301 ( 4.3A) | 1.49A | 5m5kC-4u0gA:undetectable | 5m5kC-4u0gA:18.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M66_B_ADNB502_2 (ADENOSYLHOMOCYSTEINASE) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 4 / 4 | GLN A 136THR A 183THR A 167LEU A 86 | NoneNoneNoneZIL A 301 ( 4.3A) | 1.46A | 5m66B-4u0gA:undetectable | 5m66B-4u0gA:18.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6F3M_B_ADNB502_2 (-) |
4u0g | ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2 (Mycobacteriumtuberculosis) | 4 / 4 | GLN A 136THR A 183THR A 167LEU A 86 | NoneNoneNoneZIL A 301 ( 4.3A) | 1.47A | 6f3mB-4u0gA:undetectable | 6f3mB-4u0gA:17.83 |